-
1
-
-
57449116327
-
Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies
-
Wong R, Cunningham D: Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies. J. Clin. Oncol. 26, 5668-5670 (2008).
-
(2008)
J. Clin. Oncol
, vol.26
, pp. 5668-5670
-
-
Wong, R.1
Cunningham, D.2
-
2
-
-
0035100888
-
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
-
Atkinson AJ Jr: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89-95 (2001).
-
(2001)
Clin. Pharmacol. Ther
, vol.69
, pp. 89-95
-
-
Atkinson Jr, A.J.1
-
3
-
-
0026773679
-
Identification of proteins secreted by human osteoblastic cells in culture
-
Johansen JS, Williamson MK, Rice JS, Price PA: Identification of proteins secreted by human osteoblastic cells in culture. J. Bone Miner. Res. 7, 501-512 (1992).
-
(1992)
J. Bone Miner. Res
, vol.7
, pp. 501-512
-
-
Johansen, J.S.1
Williamson, M.K.2
Rice, J.S.3
Price, P.A.4
-
4
-
-
0027505001
-
Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family
-
Hakala BE, White C, Recklies AD: Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J. Biol. Chem. 268, 25803-25810 (1993).
-
(1993)
J. Biol. Chem
, vol.268
, pp. 25803-25810
-
-
Hakala, B.E.1
White, C.2
Recklies, A.D.3
-
5
-
-
0029039184
-
Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling
-
Shackelton LM, Mann DM, Millis AJT: Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J. Biol. Chem. 270, 13076-13083 (1995).
-
(1995)
J. Biol. Chem
, vol.270
, pp. 13076-13083
-
-
Shackelton, L.M.1
Mann, D.M.2
Millis, A.J.T.3
-
6
-
-
0031571093
-
Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation
-
Rehli M, Krause SW, Andreesen R: Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 43, 221-225 (1997).
-
(1997)
Genomics
, vol.43
, pp. 221-225
-
-
Rehli, M.1
Krause, S.W.2
Andreesen, R.3
-
7
-
-
0031911418
-
Chondrex: New marker of joint disease
-
Harvey S, Weisman M, O'Dell J et al.: Chondrex: new marker of joint disease. Clin. Chem. 44, 509-516 (1998).
-
(1998)
Clin. Chem
, vol.44
, pp. 509-516
-
-
Harvey, S.1
Weisman, M.2
O'Dell, J.3
-
8
-
-
35548984723
-
Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases
-
Bussink AP, Speijer D, Aerts JM, Boot RG: Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases. Genetics 177, 959-970 (2007).
-
(2007)
Genetics
, vol.177
, pp. 959-970
-
-
Bussink, A.P.1
Speijer, D.2
Aerts, J.M.3
Boot, R.G.4
-
9
-
-
34547842599
-
Chitinase family GH18: Evolutionary insights from the genomic history of a diverse protein family
-
Funkhouser JD, Aronson NN: Chitinase family GH18: evolutionary insights from the genomic history of a diverse protein family. BMC Evol. Biol. 7, 96 (2007).
-
(2007)
BMC Evol. Biol
, vol.7
, pp. 96
-
-
Funkhouser, J.D.1
Aronson, N.N.2
-
10
-
-
34250020788
-
Family 18 chitolectins: Comparison of MGP40 and HUMGP39
-
Zaheer-ul-Haq, Dala P, Aronson NN, Madura JD: Family 18 chitolectins: comparison of MGP40 and HUMGP39. Biochem. Biophys. Res. Commun. 359, 221-226 (2007).
-
(2007)
Biochem. Biophys. Res. Commun
, vol.359
, pp. 221-226
-
-
ul-Haq, Z.1
Dala, P.2
Aronson, N.N.3
Madura, J.D.4
-
11
-
-
0037515738
-
Crystal structure of a novel regulatory 40 kDa mammary gland protein (MGP-40) secreted during involution
-
Mohanty AK, Singh G, Paramasivam M et al.: Crystal structure of a novel regulatory 40 kDa mammary gland protein (MGP-40) secreted during involution. J. Biol. Chem. 278, 14451-14460 (2003).
-
(2003)
J. Biol. Chem
, vol.278
, pp. 14451-14460
-
-
Mohanty, A.K.1
Singh, G.2
Paramasivam, M.3
-
12
-
-
0034806471
-
YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes
-
De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P: YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem. Biophys. Res. Commun. 285, 926-931 (2001).
-
(2001)
Biochem. Biophys. Res. Commun
, vol.285
, pp. 926-931
-
-
De Ceuninck, F.1
Gaufillier, S.2
Bonnaud, A.3
Sabatini, M.4
Lesur, C.5
Pastoureau, P.6
-
13
-
-
0028063457
-
Neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors
-
Morrison BW, Leder P: Neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene. 9, 3417-3426 (1994).
-
(1994)
Oncogene
, vol.9
, pp. 3417-3426
-
-
Morrison, B.W.1
Leder, P.2
-
14
-
-
0028839966
-
An abundantly secreted glycoprotein from Drosophila melanogaster is related to mammalian secretory proteins produced in rheumatoid tissues and by activated macrophages
-
Kirkpatrick RB, Matico RE, McNulty DE, Strickler JE, Rosenberg M: An abundantly secreted glycoprotein from Drosophila melanogaster is related to mammalian secretory proteins produced in rheumatoid tissues and by activated macrophages. Gene 153, 147-154 (1995).
-
(1995)
Gene
, vol.153
, pp. 147-154
-
-
Kirkpatrick, R.B.1
Matico, R.E.2
McNulty, D.E.3
Strickler, J.E.4
Rosenberg, M.5
-
15
-
-
0032937597
-
A new family of growth factors produced by the fat body and active on Drosophila imaginal disc cells
-
Kawamura K, Shibata T, Saget O, Peel D, Bryant PJ: A new family of growth factors produced by the fat body and active on Drosophila imaginal disc cells. Development 126, 211-219 (1999).
-
(1999)
Development
, vol.126
, pp. 211-219
-
-
Kawamura, K.1
Shibata, T.2
Saget, O.3
Peel, D.4
Bryant, P.J.5
-
16
-
-
33749574066
-
The phylogenetically conserved molluscan chitinase-like protein 1 (cg-clp1), homologue of human hc-gp39, stimulates proliferation and regulates synthesis of extracellular matrix components of mammalian chondrocytes
-
Badariotti F, Kypriotou M, Lelong C et al.: The phylogenetically conserved molluscan chitinase-like protein 1 (cg-clp1), homologue of human hc-gp39, stimulates proliferation and regulates synthesis of extracellular matrix components of mammalian chondrocytes. J. Biol. Chem. 281, 29583-29596 (2006).
-
(2006)
J. Biol. Chem
, vol.281
, pp. 29583-29596
-
-
Badariotti, F.1
Kypriotou, M.2
Lelong, C.3
-
17
-
-
0032518453
-
Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages
-
Renkema GH, Boot GR, Au FL et al.: Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur. J. Biochem. 251, 504-509 (1998).
-
(1998)
Eur. J. Biochem
, vol.251
, pp. 504-509
-
-
Renkema, G.H.1
Boot, G.R.2
Au, F.L.3
-
18
-
-
0141621106
-
Crystal structure and carbohydrate binding properties of the human cartilage glycoprotein-39
-
Fusetti F, Pijning T, Kalk KH, Bos E, Dijkstra BW: Crystal structure and carbohydrate binding properties of the human cartilage glycoprotein-39. J. Biol. Chem. 278, 37753-37760 (2003).
-
(2003)
J. Biol. Chem
, vol.278
, pp. 37753-37760
-
-
Fusetti, F.1
Pijning, T.2
Kalk, K.H.3
Bos, E.4
Dijkstra, B.W.5
-
19
-
-
0043031435
-
Structure and ligandinduced conformational change of the 39-kDa glycoprotein from human articular chondrocytes
-
Houston DR, Recklies AD, Krupa JC, van Aalten DMF: Structure and ligandinduced conformational change of the 39-kDa glycoprotein from human articular chondrocytes. J. Biol. Chem. 278, 30206-30212 (2003).
-
(2003)
J. Biol. Chem
, vol.278
, pp. 30206-30212
-
-
Houston, D.R.1
Recklies, A.D.2
Krupa, J.C.3
van Aalten, D.M.F.4
-
20
-
-
0030733350
-
Structural and sequence-based classification of glycoside hydrolases
-
Henrissat B, Davies G: Structural and sequence-based classification of glycoside hydrolases. Curr. Opin. Struct. Biol. 7, 637-644 (1997).
-
(1997)
Curr. Opin. Struct. Biol
, vol.7
, pp. 637-644
-
-
Henrissat, B.1
Davies, G.2
-
21
-
-
0242498371
-
Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation
-
Rehli M, Niller HH, Ammon C et al.: Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. J. Biol. Chem. 278, 44058-44067 (2003).
-
(2003)
J. Biol. Chem
, vol.278
, pp. 44058-44067
-
-
Rehli, M.1
Niller, H.H.2
Ammon, C.3
-
22
-
-
36348958365
-
YKL-40 protein expression in the early developing human musculoskeletal system
-
Johansen JS, Høyer PE, Larsen LA, Price PA, Møllgård K: YKL-40 protein expression in the early developing human musculoskeletal system. J. Histochem. Cytochem. 55, 1213-1228 (2007).
-
(2007)
J. Histochem. Cytochem
, vol.55
, pp. 1213-1228
-
-
Johansen, J.S.1
Høyer, P.E.2
Larsen, L.A.3
Price, P.A.4
Møllgård, K.5
-
23
-
-
75249092371
-
YKL-40: Common and distinct in cancer and autoimmunity, frequent in early development and abundant in human embryonic stem cells
-
Jerusalem, Israel, 2-3 September, Abstract 18
-
Johansen JS, Møllgård K: YKL-40: common and distinct in cancer and autoimmunity, frequent in early development and abundant in human embryonic stem cells. In: International Symposium Honoring Prof. David Naor. Jerusalem, Israel, 2-3 September 2007 (Abstract 18).
-
(2007)
International Symposium Honoring Prof. David Naor
-
-
Johansen, J.S.1
Møllgård, K.2
-
24
-
-
33947281563
-
YKL-40 protein expression in normal human tissues - an immunohistochemical study
-
Ringsholt M, Høgdall EVS, Johansen JS, Price PA, Christensen LH: YKL-40 protein expression in normal human tissues - an immunohistochemical study. J. Mol. Histol. 38, 33-43 (2007).
-
(2007)
J. Mol. Histol
, vol.38
, pp. 33-43
-
-
Ringsholt, M.1
Høgdall, E.V.S.2
Johansen, J.S.3
Price, P.A.4
Christensen, L.H.5
-
25
-
-
17744375604
-
Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells
-
Junker N, Johansen JS, Hansen LT, Lund EL, Kristjansen PEG: Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Cancer Sci. 96, 183-190 (2005).
-
(2005)
Cancer Sci
, vol.96
, pp. 183-190
-
-
Junker, N.1
Johansen, J.S.2
Hansen, L.T.3
Lund, E.L.4
Kristjansen, P.E.G.5
-
26
-
-
42149114566
-
Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma
-
Saidi A, Javerzat S, Bellahcene A et al.: Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. Int. J. Cancer 122, 2187-2198 (2008).
-
(2008)
Int. J. Cancer
, vol.122
, pp. 2187-2198
-
-
Saidi, A.1
Javerzat, S.2
Bellahcene, A.3
-
27
-
-
38449113410
-
Oncostatin M-induced genes in human astrocytomas
-
Krona A, Aman P, Orndal C, Josefsson A: Oncostatin M-induced genes in human astrocytomas. Int. J. Oncol. 31, 1457-1463 (2007).
-
(2007)
Int. J. Oncol
, vol.31
, pp. 1457-1463
-
-
Krona, A.1
Aman, P.2
Orndal, C.3
Josefsson, A.4
-
28
-
-
33749240157
-
Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells
-
Mylin AK, Rasmussen T, Johansen JS et al.: Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells. Eur. J. Hematol. 77, 416-424 (2006).
-
(2006)
Eur. J. Hematol
, vol.77
, pp. 416-424
-
-
Mylin, A.K.1
Rasmussen, T.2
Johansen, J.S.3
-
29
-
-
0031586597
-
Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages
-
Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M: Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp. Cell Res. 237, 46-54 (1997).
-
(1997)
Exp. Cell Res
, vol.237
, pp. 46-54
-
-
Kirkpatrick, R.B.1
Emery, J.G.2
Connor, J.R.3
Dodds, R.4
Lysko, P.G.5
Rosenberg, M.6
-
30
-
-
1842430894
-
A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkes for macrophage maturation in the U937 cell line
-
Verhoeckx KCM, Bijlsma S, De Groene EM et al.: A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkes for macrophage maturation in the U937 cell line. Proteomics 4, 1014-1028 (2004).
-
(2004)
Proteomics
, vol.4
, pp. 1014-1028
-
-
Verhoeckx, K.C.M.1
Bijlsma, S.2
De Groene, E.M.3
-
31
-
-
18244397978
-
Gene expression in papillary thyroid carcinoma reveals highly consistent profiles
-
Huang Y, Prasad M, Lemon WJ et al.: Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc. Natl. Acad. Sci. USA. 98, 15044-15049 (2001).
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 15044-15049
-
-
Huang, Y.1
Prasad, M.2
Lemon, W.J.3
-
32
-
-
0033231026
-
A public database for gene expression in human cancers
-
Lal A, Lash AE, Altschul SF et al.: A public database for gene expression in human cancers. Cancer Res. 59, 5403-5407 (1999).
-
(1999)
Cancer Res
, vol.59
, pp. 5403-5407
-
-
Lal, A.1
Lash, A.E.2
Altschul, S.F.3
-
33
-
-
0346410282
-
Differential gene expression profiling in human brain tumors
-
Markert JM, Fuller CM, Gillespie GY et al.: Differential gene expression profiling in human brain tumors. Physiol. Genomics 5, 21-33 (2001).
-
(2001)
Physiol. Genomics
, vol.5
, pp. 21-33
-
-
Markert, J.M.1
Fuller, C.M.2
Gillespie, G.Y.3
-
34
-
-
0036682413
-
Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma
-
Interesting paper about YKL-40 and glioma, •
-
Tanwar MK, Gilbert MR, Holland EC: Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res. 62, 4364-4368 (2002). • Interesting paper about YKL-40 and glioma.
-
(2002)
Cancer Res
, vol.62
, pp. 4364-4368
-
-
Tanwar, M.K.1
Gilbert, M.R.2
Holland, E.C.3
-
35
-
-
0142119394
-
HC gp-39 gene is upregulated in glioblastoma
-
Shostak K, Labunskyy V, Dmitrenko V et al.: HC gp-39 gene is upregulated in glioblastoma. Cancer Lett. 198, 203-210 (2003).
-
(2003)
Cancer Lett
, vol.198
, pp. 203-210
-
-
Shostak, K.1
Labunskyy, V.2
Dmitrenko, V.3
-
36
-
-
33646594731
-
Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using suppression subtractive hybridization
-
Colin C, Baeza N, Bartoli C et al.: Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using suppression subtractive hybridization. Oncogene 25, 2818-2829 (2006).
-
(2006)
Oncogene
, vol.25
, pp. 2818-2829
-
-
Colin, C.1
Baeza, N.2
Bartoli, C.3
-
37
-
-
20144389740
-
Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma
-
Nigro JM, Misra A, Zhang L et al.: Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res. 65, 1678-1686 (2005).
-
(2005)
Cancer Res
, vol.65
, pp. 1678-1686
-
-
Nigro, J.M.1
Misra, A.2
Zhang, L.3
-
38
-
-
33644820339
-
-
Phillips HS, Kharbanda S, Chen R et al.: Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173 (2006). •• Interesting paper about glioma.
-
Phillips HS, Kharbanda S, Chen R et al.: Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173 (2006). •• Interesting paper about glioma.
-
-
-
-
39
-
-
38449088811
-
Focused microarray analysis of glyco-gene expression in human glioblastomas
-
Kroes RA, Dawson G, Moskal JR: Focused microarray analysis of glyco-gene expression in human glioblastomas. J. Neurochem. 103, 14-24 (2007).
-
(2007)
J. Neurochem
, vol.103
, pp. 14-24
-
-
Kroes, R.A.1
Dawson, G.2
Moskal, J.R.3
-
40
-
-
44949118621
-
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
-
Ducray F, Idbaih A, de Reynies A et al.: Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. Mol. Cancer 7, 41 (2008).
-
(2008)
Mol. Cancer
, vol.7
, pp. 41
-
-
Ducray, F.1
Idbaih, A.2
de Reynies, A.3
-
41
-
-
51249101290
-
Selective repression of YKL-40 by NF-kB in glioma cell lines involves recruitment of histone deacetylase-1 and -2
-
Bhat KP, Pelloski CE, Zhang Y et al.: Selective repression of YKL-40 by NF-kB in glioma cell lines involves recruitment of histone deacetylase-1 and -2. FEBS Lett. 582, 3193-3200 (2008).
-
(2008)
FEBS Lett
, vol.582
, pp. 3193-3200
-
-
Bhat, K.P.1
Pelloski, C.E.2
Zhang, Y.3
-
42
-
-
0345074093
-
Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcomacytogenetic, molecular genetic, and cDNA microarray analyses
-
Sjögren H, Meis-Kindblom JM, Örndal C et al.: Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcomacytogenetic, molecular genetic, and cDNA microarray analyses. Am. J. Pathol. 162, 781-792 (2003).
-
(2003)
Am. J. Pathol
, vol.162
, pp. 781-792
-
-
Sjögren, H.1
Meis-Kindblom, J.M.2
Örndal, C.3
-
43
-
-
16844376506
-
YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas
-
Nutt CL, Betensky RA, Brower MA, Batchelor TT, Louis DN, Stemmer-Rachamimow AO: YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas. Clin. Cancer Res. 11, 2258-2264 (2005).
-
(2005)
Clin. Cancer Res
, vol.11
, pp. 2258-2264
-
-
Nutt, C.L.1
Betensky, R.A.2
Brower, M.A.3
Batchelor, T.T.4
Louis, D.N.5
Stemmer-Rachamimow, A.O.6
-
44
-
-
16444373329
-
YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma
-
Pelloski CE, Mahajan A, Maor M et al.: YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin. Cancer Res. 11, 3326-3334 (2005).
-
(2005)
Clin. Cancer Res
, vol.11
, pp. 3326-3334
-
-
Pelloski, C.E.1
Mahajan, A.2
Maor, M.3
-
45
-
-
34250189213
-
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma
-
Pelloski CE, Ballman KV, Furth AF et al.: Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J. Clin. Oncol. 25, 2288-2294 (2007).
-
(2007)
J. Clin. Oncol
, vol.25
, pp. 2288-2294
-
-
Pelloski, C.E.1
Ballman, K.V.2
Furth, A.F.3
-
46
-
-
33845394445
-
Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: Use of YKL-40, ApoE, ASCL1, and NKX2-2
-
Rousseau A, Nutt CL, Betensky RA et al.: Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2. J. Neuropathol. Exp. Neurol. 65, 1149-1156 (2006).
-
(2006)
J. Neuropathol. Exp. Neurol
, vol.65
, pp. 1149-1156
-
-
Rousseau, A.1
Nutt, C.L.2
Betensky, R.A.3
-
47
-
-
33847660092
-
Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer
-
Kim SH, Das K, Noreen S, Coffman F, Hameed M: Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer. World J. Surg. Oncol. 5, 17 (2007).
-
(2007)
World J. Surg. Oncol
, vol.5
, pp. 17
-
-
Kim, S.H.1
Das, K.2
Noreen, S.3
Coffman, F.4
Hameed, M.5
-
48
-
-
34548250967
-
Increased expression of the inflammatory protein YKL-40 in precancers of the breast
-
Qin W, Zhu W, Schlatter L et al.: Increased expression of the inflammatory protein YKL-40 in precancers of the breast. Int. J. Cancer 121, 1536-1542 (2007).
-
(2007)
Int. J. Cancer
, vol.121
, pp. 1536-1542
-
-
Qin, W.1
Zhu, W.2
Schlatter, L.3
-
49
-
-
33846684089
-
YKL-40 expression in benign and malignant lesions of the breast: A methodologic study
-
Roslind A, Johansen JS, Junker N et al.: YKL-40 expression in benign and malignant lesions of the breast: a methodologic study. Appl. Immunohistochem. Mol. Morphol. 15, 371-381 (2007).
-
(2007)
Appl. Immunohistochem. Mol. Morphol
, vol.15
, pp. 371-381
-
-
Roslind, A.1
Johansen, J.S.2
Junker, N.3
-
50
-
-
53949093693
-
YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer
-
Roslind A, Knoop AS, Jensen M et al.: YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer. Breast Cancer Res. Treat. 112, 275-285 (2008).
-
(2008)
Breast Cancer Res. Treat
, vol.112
, pp. 275-285
-
-
Roslind, A.1
Knoop, A.S.2
Jensen, M.3
-
51
-
-
33644518424
-
Clusterin plays an important role in hepatocellular carcinoma metastasis
-
Lau SH, Sham JST, Xie D et al.: Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene 25, 1242-1250 (2006).
-
(2006)
Oncogene
, vol.25
, pp. 1242-1250
-
-
Lau, S.H.1
Sham, J.S.T.2
Xie, D.3
-
52
-
-
20344379456
-
Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma
-
Fukushima N, Koopmann J, Sato N et al.: Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma. Mod. Pathol. 18, 779-787 (2005).
-
(2005)
Mod. Pathol
, vol.18
, pp. 779-787
-
-
Fukushima, N.1
Koopmann, J.2
Sato, N.3
-
53
-
-
17044374400
-
Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer
-
Junker N, Johansen JS, Andersen CB, Kristjansen PEG: Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer 48, 223-231 (2005).
-
(2005)
Lung Cancer
, vol.48
, pp. 223-231
-
-
Junker, N.1
Johansen, J.S.2
Andersen, C.B.3
Kristjansen, P.E.G.4
-
54
-
-
0034123291
-
+ monocytes in peripheral blood and synovium. Correlation with joint destruction in rheumatoid arthritis
-
+ monocytes in peripheral blood and synovium. Correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum. 43, 1233-1243 (2000).
-
(2000)
Arthritis Rheum
, vol.43
, pp. 1233-1243
-
-
Baeten, D.1
Boots, A.M.H.2
Steenbakkers, P.G.A.3
-
55
-
-
0035028329
-
Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology
-
Volck B, Johansen JS, Stoltenberg M et al.: Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthr. Cartil. 9, 203-214 (2001).
-
(2001)
Osteoarthr. Cartil
, vol.9
, pp. 203-214
-
-
Volck, B.1
Johansen, J.S.2
Stoltenberg, M.3
-
56
-
-
0032975495
-
Strong induction of members of the chitinase family of proteins in atherosclerosis. Chitotriosidase and human cartilage gp-39 expressed in lesion macrophages
-
Boot RG, van Achterberg TAE, van Aken BE et al.: Strong induction of members of the chitinase family of proteins in atherosclerosis. Chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler. Thromb. Vasc. Biol. 19, 687-694 (1999).
-
(1999)
Arterioscler. Thromb. Vasc. Biol
, vol.19
, pp. 687-694
-
-
Boot, R.G.1
van Achterberg, T.A.E.2
van Aken, B.E.3
-
57
-
-
36148981436
-
A chitinase-like protein in the lung and circulation of patients with severe asthma
-
Chupp GL, Lee CG, Jarjour N et al.: A chitinase-like protein in the lung and circulation of patients with severe asthma. N. Engl. J. Med. 357, 2016-2027 (2007).
-
(2007)
N. Engl. J. Med
, vol.357
, pp. 2016-2027
-
-
Chupp, G.L.1
Lee, C.G.2
Jarjour, N.3
-
58
-
-
0033513295
-
YKL-40 in giant cells and macrophages from patients with giant cell arteritis
-
Johansen JS, Baslund B, Garbarsch C et al.: YKL-40 in giant cells and macrophages from patients with giant cell arteritis. Arthritis Rheum. 42, 2624-2630 (1999).
-
(1999)
Arthritis Rheum
, vol.42
, pp. 2624-2630
-
-
Johansen, J.S.1
Baslund, B.2
Garbarsch, C.3
-
59
-
-
14844284556
-
Increased serum YKL-40 in patients with pulmonary sarcoidosis. A potential marker of disease activity?
-
Johansen JS, Milman N, Hansen M, Garbarsch C, Price PA, Graudal N: Increased serum YKL-40 in patients with pulmonary sarcoidosis. A potential marker of disease activity? Respir. Med. 99, 396-402 (2005).
-
(2005)
Respir. Med
, vol.99
, pp. 396-402
-
-
Johansen, J.S.1
Milman, N.2
Hansen, M.3
Garbarsch, C.4
Price, P.A.5
Graudal, N.6
-
60
-
-
0031819084
-
YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils
-
Volck B, Price PA, Johansen JS et al.: YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc. Assoc. Am. Phys. 110, 351-360 (1998).
-
(1998)
Proc. Assoc. Am. Phys
, vol.110
, pp. 351-360
-
-
Volck, B.1
Price, P.A.2
Johansen, J.S.3
-
62
-
-
0030785775
-
Plasma YKL-40: A new potential marker of fibrosis in patients with alcoholic cirrhosis?
-
Johansen JS, Møller S, Price PA et al.: Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis? Scand. J. Gastroenterol. 32, 582-590 (1997).
-
(1997)
Scand. J. Gastroenterol
, vol.32
, pp. 582-590
-
-
Johansen, J.S.1
Møller, S.2
Price, P.A.3
-
63
-
-
0034041067
-
Serum YKL-40 is increased in patients with hepatic fibrosis
-
Johansen JS, Christoffersen P, Møller S et al.: Serum YKL-40 is increased in patients with hepatic fibrosis. J. Hepatol. 32, 911-920
-
J. Hepatol
, vol.32
, pp. 911-920
-
-
Johansen, J.S.1
Christoffersen, P.2
Møller, S.3
-
64
-
-
0035054253
-
Regulation of YKL-40 production by human articular chondrocytes
-
Johansen JS, Olee T, Price PA, Hashimoto S, Ochs RL, Lotz M: Regulation of YKL-40 production by human articular chondrocytes. Arthritis Rheum. 44, 826-837 (2001).
-
(2001)
Arthritis Rheum
, vol.44
, pp. 826-837
-
-
Johansen, J.S.1
Olee, T.2
Price, P.A.3
Hashimoto, S.4
Ochs, R.L.5
Lotz, M.6
-
65
-
-
0021895145
-
Isolation and characterization of a Mr = 38,000 protein from differentiating smooth muscle cells
-
Millis AJT, Hoyle M, Reich E, Mann DM: Isolation and characterization of a Mr = 38,000 protein from differentiating smooth muscle cells. J. Biol. Chem. 260, 3754-3761 (1985).
-
(1985)
J. Biol. Chem
, vol.260
, pp. 3754-3761
-
-
Millis, A.J.T.1
Hoyle, M.2
Reich, E.3
Mann, D.M.4
-
66
-
-
0022453659
-
In vitro expression of a 38,000 dalton heparin-binding glycoprotein by morphologically differentiated smooth muscle cells
-
Millis AJT, Hoyle M, Kent L: In vitro expression of a 38,000 dalton heparin-binding glycoprotein by morphologically differentiated smooth muscle cells. J. Cell Physiol. 127, 366-372 (1986).
-
(1986)
J. Cell Physiol
, vol.127
, pp. 366-372
-
-
Millis, A.J.T.1
Hoyle, M.2
Kent, L.3
-
67
-
-
0033542726
-
Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells
-
Malinda KM, Ponce L, Kleinman HK, Shackelton LM, Millis AJT: Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp. Cell Res. 250, 168-173 (1999).
-
(1999)
Exp. Cell Res
, vol.250
, pp. 168-173
-
-
Malinda, K.M.1
Ponce, L.2
Kleinman, H.K.3
Shackelton, L.M.4
Millis, A.J.T.5
-
68
-
-
0037530029
-
gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells
-
Nishikawa KC, Millis AJT: gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp. Cell Res. 287, 79-87 (2003).
-
(2003)
Exp. Cell Res
, vol.287
, pp. 79-87
-
-
Nishikawa, K.C.1
Millis, A.J.T.2
-
69
-
-
0025316422
-
Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period
-
Nyirkos P, Golds EE: Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period. Biochem. J. 68, 265-268 (1990).
-
(1990)
Biochem. J
, vol.68
, pp. 265-268
-
-
Nyirkos, P.1
Golds, E.E.2
-
70
-
-
18844386707
-
The synovial proteome: Analysis of fibroblast-like synoviocytes
-
Dasuri K, Antonovici M, Chen K et al.: The synovial proteome: analysis of fibroblast-like synoviocytes. Arthritis Res. Ther. 6, R161-R168 (2004).
-
(2004)
Arthritis Res. Ther
, vol.6
-
-
Dasuri, K.1
Antonovici, M.2
Chen, K.3
-
71
-
-
32044473062
-
Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells
-
Mizoguchi E: Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells. Gastroenterology 130, 398-411 (2006).
-
(2006)
Gastroenterology
, vol.130
, pp. 398-411
-
-
Mizoguchi, E.1
-
72
-
-
34249684451
-
A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker
-
Kruit A, Grutters JC, Ruven HJT, van Moorsel CC, van den Bosch JM: A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respir. Med. 101, 1563-1571 (2007).
-
(2007)
Respir. Med
, vol.101
, pp. 1563-1571
-
-
Kruit, A.1
Grutters, J.C.2
Ruven, H.J.T.3
van Moorsel, C.C.4
van den Bosch, J.M.5
-
73
-
-
42249103640
-
Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function
-
Ober C, Tan Z, Sun Y et al.: Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N. Engl. J. Med. 358, 1682-1691 (2008).
-
(2008)
N. Engl. J. Med
, vol.358
, pp. 1682-1691
-
-
Ober, C.1
Tan, Z.2
Sun, Y.3
-
74
-
-
58149316013
-
-
Berres ML, Papen S, Pauels K et al.: A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection. J. Hepatol. 50, 370-376 (2009). • Discusses the relationship between variation in CHI3L1, serum YKL-40 and liver fibrosis.
-
Berres ML, Papen S, Pauels K et al.: A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection. J. Hepatol. 50, 370-376 (2009). • Discusses the relationship between variation in CHI3L1, serum YKL-40 and liver fibrosis.
-
-
-
-
75
-
-
33846005875
-
Functional variants in the promoter region of chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia
-
Zhao X, Tang R, Gao B et al.: Functional variants in the promoter region of chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia. Am. J. Hum. Genet. 80, 12-18 (2007).
-
(2007)
Am. J. Hum. Genet
, vol.80
, pp. 12-18
-
-
Zhao, X.1
Tang, R.2
Gao, B.3
-
76
-
-
45449116310
-
Chitinase-3-like 1 (CHI3L1) gene and schizophrenia: Genetic association and a potential functional mechanism
-
Yang MS, Morris DW, Donohoe G et al.: Chitinase-3-like 1 (CHI3L1) gene and schizophrenia: genetic association and a potential functional mechanism. Biol. Psychiatry 64, 98-103 (2008).
-
(2008)
Biol. Psychiatry
, vol.64
, pp. 98-103
-
-
Yang, M.S.1
Morris, D.W.2
Donohoe, G.3
-
77
-
-
68949194091
-
No association of (-131C->G) variant of CHI3L1 gene with risk of glioblastoma and prognosis
-
Boisselier B, Marie Y, El Hallani S et al.: No association of (-131C->G) variant of CHI3L1 gene with risk of glioblastoma and prognosis. J. Neurooncol. 94(2), 169-172 (2009) .
-
(2009)
J. Neurooncol
, vol.94
, Issue.2
, pp. 169-172
-
-
Boisselier, B.1
Marie, Y.2
El Hallani, S.3
-
78
-
-
65549120282
-
Variation in CHI3L1 in relation to Type 2 diabetes and related quantitative traits
-
Rathcke CN, Holmkvist J, Jørgensen T et al.: Variation in CHI3L1 in relation to Type 2 diabetes and related quantitative traits. PLoS ONE 4, E5469 (2009).
-
(2009)
PLoS ONE
, vol.4
-
-
Rathcke, C.N.1
Holmkvist, J.2
Jørgensen, T.3
-
79
-
-
33646842919
-
Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodeling, fibrosis and cancer
-
Johansen JS: Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodeling, fibrosis and cancer. Dan. Med. Bull. 53, 172-209 (2006).
-
(2006)
Dan. Med. Bull
, vol.53
, pp. 172-209
-
-
Johansen, J.S.1
-
80
-
-
33644782522
-
Serum YKL-40, a new prognostic biomarker in cancer patients?
-
Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA: Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiol. Biomarkers Prev. 15, 194-202 (2006).
-
(2006)
Cancer Epidemiol. Biomarkers Prev
, vol.15
, pp. 194-202
-
-
Johansen, J.S.1
Jensen, B.V.2
Roslind, A.3
Nielsen, D.4
Price, P.A.5
-
81
-
-
33846698779
-
Is YKL-40 a new therapeutic target in cancer?
-
Johansen JS, Jensen BV, Roslind A, Price PA: Is YKL-40 a new therapeutic target in cancer? Expert Opin. Ther. Targets 11, 219-234 (2007).
-
(2007)
Expert Opin. Ther. Targets
, vol.11
, pp. 219-234
-
-
Johansen, J.S.1
Jensen, B.V.2
Roslind, A.3
Price, P.A.4
-
82
-
-
0036645699
-
The chitinase 3-like protein human cartilage 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase-and protein kinase B-mediated signalling pathways
-
Recklies AD, White C, Ling H: The chitinase 3-like protein human cartilage 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase-and protein kinase B-mediated signalling pathways. Biochem. J. 365, 119-126 (2002).
-
(2002)
Biochem. J
, vol.365
, pp. 119-126
-
-
Recklies, A.D.1
White, C.2
Ling, H.3
-
83
-
-
29244441691
-
Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes
-
Recklies AD, Ling H, White C, Bernier SM: Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes. J. Biol. Chem. 280, 41213-41221 (2005).
-
(2005)
J. Biol. Chem
, vol.280
, pp. 41213-41221
-
-
Recklies, A.D.1
Ling, H.2
White, C.3
Bernier, S.M.4
-
84
-
-
3042739230
-
The chitinase 3-like protein human cartilage glycoproein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha
-
Ling H, Recklies AD: The chitinase 3-like protein human cartilage glycoproein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. Biochem. J. 380, 651-659 (2004).
-
(2004)
Biochem. J
, vol.380
, pp. 651-659
-
-
Ling, H.1
Recklies, A.D.2
-
85
-
-
33746046387
-
Prognostic associations of activated mitogen-activated protein kinase and akt pathways in glioblastoma
-
Pelloski CE, Lin E, Zhang L et al.: Prognostic associations of activated mitogen-activated protein kinase and akt pathways in glioblastoma. Clin. Cancer Res. 12, 3935-3941 (2006).
-
(2006)
Clin. Cancer Res
, vol.12
, pp. 3935-3941
-
-
Pelloski, C.E.1
Lin, E.2
Zhang, L.3
-
87
-
-
0022891340
-
Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
-
Dvorak HF: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659 (1986).
-
(1986)
N. Engl. J. Med
, vol.315
, pp. 1650-1659
-
-
Dvorak, H.F.1
-
88
-
-
0035901090
-
Inflammation and cancer: Back to Virchow?
-
Balkwill F, Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357, 539-545 (2001).
-
(2001)
Lancet
, vol.357
, pp. 539-545
-
-
Balkwill, F.1
Mantovani, A.2
-
89
-
-
4644335311
-
An inflammatory link
-
Balkwill F, Coussens LM: An inflammatory link. Nature 431, 405-406 (2004).
-
(2004)
Nature
, vol.431
, pp. 405-406
-
-
Balkwill, F.1
Coussens, L.M.2
-
90
-
-
17644394616
-
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
-
Balkwill F, Charles KA, Mantovani A: Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211-217 (2005).
-
(2005)
Cancer Cell
, vol.7
, pp. 211-217
-
-
Balkwill, F.1
Charles, K.A.2
Mantovani, A.3
-
91
-
-
0037180757
-
Inflammation and cancer
-
Coussens LM, Werb Z: Inflammation and cancer. Nature 420, 860-867 (2002).
-
(2002)
Nature
, vol.420
, pp. 860-867
-
-
Coussens, L.M.1
Werb, Z.2
-
92
-
-
12144285600
-
Proteases, extracellular matrix, and cancer
-
DeClerck YA, Mercurio AM, Stack MS et al.: Proteases, extracellular matrix, and cancer. Am. J. Pathol. 164, 1131-1139 (2004).
-
(2004)
Am. J. Pathol
, vol.164
, pp. 1131-1139
-
-
DeClerck, Y.A.1
Mercurio, A.M.2
Stack, M.S.3
-
93
-
-
20344376407
-
Mechanisms of disease: Inflammation and the origins of cancer
-
Moss SF, Blaser MJ: Mechanisms of disease: inflammation and the origins of cancer. Nat. Clin. Pract. Oncol. 2, 90-97 (2005).
-
(2005)
Nat. Clin. Pract. Oncol
, vol.2
, pp. 90-97
-
-
Moss, S.F.1
Blaser, M.J.2
-
94
-
-
30144443269
-
Paradoxical roles of the immune system during cancer development
-
De Visser KE, Eichten A, Coussens LM: Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6, 24-37 (2006).
-
(2006)
Nat. Rev. Cancer
, vol.6
, pp. 24-37
-
-
De Visser, K.E.1
Eichten, A.2
Coussens, L.M.3
-
96
-
-
34248141100
-
A cytokine-mediated link between immunity, inflammation, and cancer
-
Lin WW, Karin M: A cytokine-mediated link between immunity, inflammation, and cancer. J. Clin. Invest. 117, 1175-1183 (2007).
-
(2007)
J. Clin. Invest
, vol.117
, pp. 1175-1183
-
-
Lin, W.W.1
Karin, M.2
-
97
-
-
0029563126
-
The role of fibroblasts in tumor behavior
-
Gregoire M, Lieubeau B: The role of fibroblasts in tumor behavior. Cancer Met. Rev. 14, 339-350 (1995).
-
(1995)
Cancer Met. Rev
, vol.14
, pp. 339-350
-
-
Gregoire, M.1
Lieubeau, B.2
-
99
-
-
0242268883
-
Tumor reversion: Correction of malignant behavior by microenvironmental cues
-
Kenny PA, Bissell MJ: Tumor reversion: correction of malignant behavior by microenvironmental cues. Int. J. Cancer 107, 688-695 (2003).
-
(2003)
Int. J. Cancer
, vol.107
, pp. 688-695
-
-
Kenny, P.A.1
Bissell, M.J.2
-
100
-
-
0347302952
-
Cytokines in cancer pathogenesis and cancer therapy
-
Dranoff G: Cytokines in cancer pathogenesis and cancer therapy. Nat. Rev. Cancer. 4, 11-22 (2004).
-
(2004)
Nat. Rev. Cancer
, vol.4
, pp. 11-22
-
-
Dranoff, G.1
-
101
-
-
36148937125
-
Tumour vascularization: Sprouting angiogenesis and beyond
-
Hillen F, Griffioen AW: Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev. 26, 489-502 (2007).
-
(2007)
Cancer Metastasis Rev
, vol.26
, pp. 489-502
-
-
Hillen, F.1
Griffioen, A.W.2
-
102
-
-
0029858539
-
Differential screening identifies genetic markers of monocyte to macrophage maturation
-
Krause SW, Rehli M, Kreutz M, Schwarzfisher L, Paulauski JD, Andreesen R: Differential screening identifies genetic markers of monocyte to macrophage maturation. J. Leukocyte Biol. 60, 540-545 (1996).
-
(1996)
J. Leukocyte Biol
, vol.60
, pp. 540-545
-
-
Krause, S.W.1
Rehli, M.2
Kreutz, M.3
Schwarzfisher, L.4
Paulauski, J.D.5
Andreesen, R.6
-
103
-
-
0033178501
-
Serial analysis of gene expression in human monocytes and macrophages
-
Hashimoto S, Suzuki T, Dong HY, Yamazaki N, Matsushima K: Serial analysis of gene expression in human monocytes and macrophages. Blood 94, 837-844 (1999).
-
(1999)
Blood
, vol.94
, pp. 837-844
-
-
Hashimoto, S.1
Suzuki, T.2
Dong, H.Y.3
Yamazaki, N.4
Matsushima, K.5
-
104
-
-
0034307661
-
Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE
-
Suzuki T, Hashimoto S, Toyoda N et al.: Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE. Blood 96, 2584-2591 (2000).
-
(2000)
Blood
, vol.96
, pp. 2584-2591
-
-
Suzuki, T.1
Hashimoto, S.2
Toyoda, N.3
-
105
-
-
0036295210
-
Molecular analysis of expansion, differentiation, and growth factor treatment of human chondrocytes identifies differentiation markers and growth-related genes
-
Benz K, Breit S, Lukoschek M, Mau H, Richter W: Molecular analysis of expansion, differentiation, and growth factor treatment of human chondrocytes identifies differentiation markers and growth-related genes. Biochem. Biophys. Res. Commun. 293, 284-292 (2002).
-
(2002)
Biochem. Biophys. Res. Commun
, vol.293
, pp. 284-292
-
-
Benz, K.1
Breit, S.2
Lukoschek, M.3
Mau, H.4
Richter, W.5
-
106
-
-
0036166257
-
Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis
-
Stokes DG, Liu G, Coimbra IB, Piera-Velazquez S, Crowl RM, Jimenez SA: Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis. Arthritis Rheum. 46, 404-419 (2002).
-
(2002)
Arthritis Rheum
, vol.46
, pp. 404-419
-
-
Stokes, D.G.1
Liu, G.2
Coimbra, I.B.3
Piera-Velazquez, S.4
Crowl, R.M.5
Jimenez, S.A.6
-
107
-
-
0038149011
-
Redifferentiation of dedifferentiated chondrocytes and chondrogenesis of human bone marrow stromal cells via chondrosphere formation with expression profiling by large-scale cDNA analysis
-
Imabayashi H, Mori T, Gojo S et al.: Redifferentiation of dedifferentiated chondrocytes and chondrogenesis of human bone marrow stromal cells via chondrosphere formation with expression profiling by large-scale cDNA analysis. Exp. Cell Res. 288, 35-50 (2003).
-
(2003)
Exp. Cell Res
, vol.288
, pp. 35-50
-
-
Imabayashi, H.1
Mori, T.2
Gojo, S.3
-
108
-
-
33846380636
-
HC-gp39 contributes to chondrocyte differentiation by inducing SOX9 and type II collagen expressions
-
Jacques C, Recklies AD, Levy A, Berenbaum F: HC-gp39 contributes to chondrocyte differentiation by inducing SOX9 and type II collagen expressions. Osteoarthr. Cartil. 15, 138-146 (2007).
-
(2007)
Osteoarthr. Cartil
, vol.15
, pp. 138-146
-
-
Jacques, C.1
Recklies, A.D.2
Levy, A.3
Berenbaum, F.4
-
109
-
-
33645727755
-
Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway
-
Kzhyshkowska J, Mamidi S, Gratchev A et al.: Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 107, 3221-3228 (2006).
-
(2006)
Blood
, vol.107
, pp. 3221-3228
-
-
Kzhyshkowska, J.1
Mamidi, S.2
Gratchev, A.3
-
110
-
-
33746351501
-
The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen fibril formation
-
Bigg HF, Wait R, Rowan AD, Cawston TE: The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen fibril formation. J. Biol.Chem. 281, 21082-21095 (2006).
-
(2006)
J. Biol.Chem
, vol.281
, pp. 21082-21095
-
-
Bigg, H.F.1
Wait, R.2
Rowan, A.D.3
Cawston, T.E.4
-
111
-
-
0029955223
-
Cells expressing the DG42 gene from early Xenopus embryos synthesize hyaluronan
-
Meyer MF, Kreil G: Cells expressing the DG42 gene from early Xenopus embryos synthesize hyaluronan. Proc. Natl Acad. Sci. USA 93, 4543-4547 (1996).
-
(1996)
Proc. Natl Acad. Sci. USA
, vol.93
, pp. 4543-4547
-
-
Meyer, M.F.1
Kreil, G.2
-
112
-
-
0029900197
-
Homologs of the Xenopus developmental gene DG42 are present in zebrafish and mouse and are involved in the synthesis of Nod-like chitin oligosaccharides during early embryogenesis
-
Semino CE, Specht CA, Raimondi A, Robbins PW: Homologs of the Xenopus developmental gene DG42 are present in zebrafish and mouse and are involved in the synthesis of Nod-like chitin oligosaccharides during early embryogenesis. Proc. Natl Acad. Sci. USA 93, 4548-4553 (1996).
-
(1996)
Proc. Natl Acad. Sci. USA
, vol.93
, pp. 4548-4553
-
-
Semino, C.E.1
Specht, C.A.2
Raimondi, A.3
Robbins, P.W.4
-
113
-
-
0029900514
-
Does DG42 synthesize hyaluronan or chitin? A controversy about oligosaccharides in vertebrate development
-
Varki A: Does DG42 synthesize hyaluronan or chitin? A controversy about oligosaccharides in vertebrate development. Proc. Natl Acad. Sci. USA 93, 4523-4525 (1996).
-
(1996)
Proc. Natl Acad. Sci. USA
, vol.93
, pp. 4523-4525
-
-
Varki, A.1
-
114
-
-
3042697038
-
Hyaluronan: From extracellular glue to pericellular cue
-
Toole BP: Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4, 528-539 (2004).
-
(2004)
Nat. Rev. Cancer
, vol.4
, pp. 528-539
-
-
Toole, B.P.1
-
115
-
-
24144477955
-
Decreasing the metastatic potential in cancers - targeting the heparan sulfate proteoglycans
-
Fjeldstad K, Kolset SO: Decreasing the metastatic potential in cancers - targeting the heparan sulfate proteoglycans. Curr. Drug Targets 6, 665-682 (2005).
-
(2005)
Curr. Drug Targets
, vol.6
, pp. 665-682
-
-
Fjeldstad, K.1
Kolset, S.O.2
-
116
-
-
0030904638
-
Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis
-
Verheiden GFM, Rijnders AWM, Bos E et al.: Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum. 40, 1115-1125 (1997).
-
(1997)
Arthritis Rheum
, vol.40
, pp. 1115-1125
-
-
Verheiden, G.F.M.1
Rijnders, A.W.M.2
Bos, E.3
-
117
-
-
0033509783
-
T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles
-
Cope AP, Patel SD, Hall F et al.: T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles. Arthritis. Rheum. 42, 1497-1507 (1999).
-
(1999)
Arthritis. Rheum
, vol.42
, pp. 1497-1507
-
-
Cope, A.P.1
Patel, S.D.2
Hall, F.3
-
118
-
-
0034090082
-
Induction of tolerance with intranasal administration of human cartilage gp-39 in DBA/1 mice
-
Joosten LAB, Coenen de-Roo CJJ, Helsen MMA et al.: Induction of tolerance with intranasal administration of human cartilage gp-39 in DBA/1 mice. Arthritis Rheum. 43, 645-655 (2000).
-
(2000)
Arthritis Rheum
, vol.43
, pp. 645-655
-
-
Joosten, L.A.B.1
Coenen de-Roo, C.J.J.2
Helsen, M.M.A.3
-
119
-
-
0034502183
-
Cellular immune response to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditions
-
Vos K, Miltenburg AMM, van Meijgaarden KE et al.: Cellular immune response to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditions. Rheumatology 39, 1326-1331 (2000).
-
(2000)
Rheumatology
, vol.39
, pp. 1326-1331
-
-
Vos, K.1
Miltenburg, A.M.M.2
van Meijgaarden, K.E.3
-
120
-
-
0035165288
-
Autoantigenic HCgp39 epitopes are presented by the HLA-DM-dependent presentation pathway in human B cells
-
Patil NS, Hall FC, Drover S et al.: Autoantigenic HCgp39 epitopes are presented by the HLA-DM-dependent presentation pathway in human B cells. J. Immunol. 166, 33-41 (2001).
-
(2001)
J. Immunol
, vol.166
, pp. 33-41
-
-
Patil, N.S.1
Hall, F.C.2
Drover, S.3
-
121
-
-
0037334236
-
Allele and antigen-specific treatment of rheumatoid arthritis: A double blind, placebo controlled Phase 1 trial
-
Kavanaugh A, Genovese M, Baughman J et al.: Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled Phase 1 trial. J. Rheumatol. 30, 449-454 (2003).
-
(2003)
J. Rheumatol
, vol.30
, pp. 449-454
-
-
Kavanaugh, A.1
Genovese, M.2
Baughman, J.3
-
122
-
-
0038188762
-
Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies
-
Steenbakkers PGA, Baeten D, Rovers E et al.: Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies. J. Immunol. 170, 5719-5727 (2003).
-
(2003)
J. Immunol
, vol.170
, pp. 5719-5727
-
-
Steenbakkers, P.G.A.1
Baeten, D.2
Rovers, E.3
-
123
-
-
36148984547
-
Exoskeletons and exhalation
-
Dickey BF: Exoskeletons and exhalation. N. Engl. J. Med. 357, 2082-2084 (2007).
-
(2007)
N. Engl. J. Med
, vol.357
, pp. 2082-2084
-
-
Dickey, B.F.1
-
124
-
-
66049139534
-
Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis
-
Lee CG, Hartl D, Lee GR et al.: Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J. Exp. Med. 206, 1149-1166 (2009).
-
(2009)
J. Exp. Med
, vol.206
, pp. 1149-1166
-
-
Lee, C.G.1
Hartl, D.2
Lee, G.R.3
-
125
-
-
46749131543
-
YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor
-
Bonneh-Barkay D, Bissel SJ, Wang G et al.: YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor. Am. J. Pathol. 173, 130-143 (2008).
-
(2008)
Am. J. Pathol
, vol.173
, pp. 130-143
-
-
Bonneh-Barkay, D.1
Bissel, S.J.2
Wang, G.3
-
126
-
-
46749109277
-
YKL-40: A candidate biomarker for simian immunodeficiency virus and human immunodeficiency virus encephalitis
-
Kolson DL: YKL-40: a candidate biomarker for simian immunodeficiency virus and human immunodeficiency virus encephalitis. Am. J. Pathol. 173, 25-29 (2008).
-
(2008)
Am. J. Pathol
, vol.173
, pp. 25-29
-
-
Kolson, D.L.1
-
127
-
-
34248395455
-
Is the sugar always sweet in intestinal inflammation?
-
Mizoguchi E, Mizoguchi A: Is the sugar always sweet in intestinal inflammation? Immunol. Res. 37, 47-60 (2007).
-
(2007)
Immunol. Res
, vol.37
, pp. 47-60
-
-
Mizoguchi, E.1
Mizoguchi, A.2
-
128
-
-
48749084100
-
Chitinase 3-like-1 enhances bacterial adhesion to colonic epithelial cells through the interaction with bacterial chitin-binding protein
-
Kawada M, Chen CC, Arihiro A, Nagatani K, Watanabe T, Mizoguchi E: Chitinase 3-like-1 enhances bacterial adhesion to colonic epithelial cells through the interaction with bacterial chitin-binding protein. Lab. Invest. 88, 883-895 (2008).
-
(2008)
Lab. Invest
, vol.88
, pp. 883-895
-
-
Kawada, M.1
Chen, C.C.2
Arihiro, A.3
Nagatani, K.4
Watanabe, T.5
Mizoguchi, E.6
-
129
-
-
33847327365
-
Benchmarks for the assessment of novel cardiovascular biomarkers
-
Morrow DA, de Lemos JA: Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 115, 949-952 (2007).
-
(2007)
Circulation
, vol.115
, pp. 949-952
-
-
Morrow, D.A.1
de Lemos, J.A.2
-
130
-
-
65549120037
-
YKL-40: A novel marker shared by chronic inflammation and oncogenic transformation
-
Roslind A, Johansen JS: YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. Methods Mol. Biol. 511, 159-184 (2009).
-
(2009)
Methods Mol. Biol
, vol.511
, pp. 159-184
-
-
Roslind, A.1
Johansen, J.S.2
-
132
-
-
0036113515
-
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
-
Østergaard C, Johansen JS, Benfield T, Price PA, Lundgren JD: YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin. Diagn. Lab. Immun. 9, 598-604 (2002).
-
(2002)
Clin. Diagn. Lab. Immun
, vol.9
, pp. 598-604
-
-
Østergaard, C.1
Johansen, J.S.2
Benfield, T.3
Price, P.A.4
Lundgren, J.D.5
-
133
-
-
48449096280
-
Elevated cerebrospinal fluid and serum YKL-40 levels are not associated with symptomatic vasospasm in patients with aneurysmal subarachnoid haemorrhage
-
Kacira T, Hanimoglu H, Kucur M et al.: Elevated cerebrospinal fluid and serum YKL-40 levels are not associated with symptomatic vasospasm in patients with aneurysmal subarachnoid haemorrhage. J. Clin. Neuroscience 15, 1011-1016 (2008).
-
(2008)
J. Clin. Neuroscience
, vol.15
, pp. 1011-1016
-
-
Kacira, T.1
Hanimoglu, H.2
Kucur, M.3
-
134
-
-
0029924794
-
Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint
-
Johansen JS, Hvolris J, Hansen M, Backer V, Lorenzen I, Price PA: Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br. J. Rheumatol. 35, 553-559 (1996).
-
(1996)
Br. J. Rheumatol
, vol.35
, pp. 553-559
-
-
Johansen, J.S.1
Hvolris, J.2
Hansen, M.3
Backer, V.4
Lorenzen, I.5
Price, P.A.6
-
135
-
-
33644766789
-
Genetic effects on serum levels of human cartilage glycoprotein-39 (YKL-40) in a pedigreed baboon model for age-related changes and pathology in bone
-
Abstract
-
Mahaney MC, Czerwinski SA, Rogers J: Genetic effects on serum levels of human cartilage glycoprotein-39 (YKL-40) in a pedigreed baboon model for age-related changes and pathology in bone. Am. Soc. Bone Miner. Res. (1998) (Abstract SA121).
-
(1998)
Am. Soc. Bone Miner. Res
-
-
Mahaney, M.C.1
Czerwinski, S.A.2
Rogers, J.3
-
136
-
-
0035197246
-
Serum YKL-40 is associated with osteoarthritis and atherosclerosis in nonhuman primates
-
Register TC
-
Register TC, Carlson CS, Adams MR: Serum YKL-40 is associated with osteoarthritis and atherosclerosis in nonhuman primates. Clin. Chem. 47, 2159-2161 (2001).
-
(2001)
Clin. Chem
, vol.47
, pp. 2159-2161
-
-
Carlson, C.S.1
Adams, M.R.2
-
137
-
-
0033867455
-
Stability of YKL-40 concentration in blood samples
-
Høgdall EVS, Johansen JS, Kjaer SK, Price PA, Blaakjaer J, Høgdall CK: Stability of YKL-40 concentration in blood samples. Scand. J. Clin. Lab. Invest. 60, 247-252 (2000).
-
(2000)
Scand. J. Clin. Lab. Invest
, vol.60
, pp. 247-252
-
-
Høgdall, E.V.S.1
Johansen, J.S.2
Kjaer, S.K.3
Price, P.A.4
Blaakjaer, J.5
Høgdall, C.K.6
-
138
-
-
0027430967
-
A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid
-
Johansen JS, Jensen HS, Price PA: A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br. J. Rheumatol. 32, 949-955 (1993).
-
(1993)
Br. J. Rheumatol
, vol.32
, pp. 949-955
-
-
Johansen, J.S.1
Jensen, H.S.2
Price, P.A.3
-
139
-
-
54249128937
-
Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects
-
Discusses variations in serum YKL-40 levels, •
-
Johansen JS, Lottenburger T, Nielsen HJ et al.: Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects. Cancer Epidemiol. Biomarkers Prev. 17, 2603-2608 (2008). • Discusses variations in serum YKL-40 levels.
-
(2008)
Cancer Epidemiol. Biomarkers Prev
, vol.17
, pp. 2603-2608
-
-
Johansen, J.S.1
Lottenburger, T.2
Nielsen, H.J.3
-
140
-
-
59149100287
-
Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population
-
Addresses YKL-40 and the prediction of gastrointestinal cancer, ••
-
Johansen JS, Bojesen SE, Mylin AK, Frikke-Schmidt R, Price PA, Nordestgaard BG: Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population. J. Clin. Oncology 27, 572-578 (2009). •• Addresses YKL-40 and the prediction of gastrointestinal cancer.
-
(2009)
J. Clin. Oncology
, vol.27
, pp. 572-578
-
-
Johansen, J.S.1
Bojesen, S.E.2
Mylin, A.K.3
Frikke-Schmidt, R.4
Price, P.A.5
Nordestgaard, B.G.6
-
141
-
-
37849030677
-
High serum YKL-40 level in a cohort of 80-years old is associated with increased risk of all-cause mortality
-
Johansen JS, Pedersen AN, Schroll M, Jørgensen T, Pedersen BK, Bruunsgaard H: High serum YKL-40 level in a cohort of 80-years old is associated with increased risk of all-cause mortality. Clin. Exp. Immunol. 151, 260-266 (2008).
-
(2008)
Clin. Exp. Immunol
, vol.151
, pp. 260-266
-
-
Johansen, J.S.1
Pedersen, A.N.2
Schroll, M.3
Jørgensen, T.4
Pedersen, B.K.5
Bruunsgaard, H.6
-
142
-
-
0033545342
-
Acute-phase proteins and other systemic responses to inflammation
-
Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448-454 (1999).
-
(1999)
N. Engl. J. Med
, vol.340
, pp. 448-454
-
-
Gabay, C.1
Kushner, I.2
-
143
-
-
31444437678
-
What does minor elevation of C-reactive protein signify?
-
Kushner I, Rzewnicki D, Samols D: What does minor elevation of C-reactive protein signify? Am. J. Med. 119, 166, E17-E28 (2006).
-
(2006)
Am. J. Med
, vol.119
, Issue.166
-
-
Kushner, I.1
Rzewnicki, D.2
Samols, D.3
-
144
-
-
0032704645
-
YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization
-
Nordenbæk C, Johansen JS, Junker P, Borregaard N, Sørensen O, Price PA: YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization. J. Infect. Dis. 180, 1722-1726 (1999).
-
(1999)
J. Infect. Dis
, vol.180
, pp. 1722-1726
-
-
Nordenbæk, C.1
Johansen, J.S.2
Junker, P.3
Borregaard, N.4
Sørensen, O.5
Price, P.A.6
-
145
-
-
0035987161
-
Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease
-
Kronborg G, Østergaard, Weis N et al.: Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Scand. J. Infect. Dis. 34, 323-326 (2002).
-
(2002)
Scand. J. Infect. Dis
, vol.34
, pp. 323-326
-
-
Kronborg, G.1
Østergaard, W.N.2
-
146
-
-
17644387250
-
Circulating YKL-40 levels during human endotoxaemia
-
Johansen JS, Krabbe K, Møller K, Pedersen BK: Circulating YKL-40 levels during human endotoxaemia. Clin. Exp. Immunol. 140, 343-348 (2005).
-
(2005)
Clin. Exp. Immunol
, vol.140
, pp. 343-348
-
-
Johansen, J.S.1
Krabbe, K.2
Møller, K.3
Pedersen, B.K.4
-
147
-
-
0032706496
-
Serum YKL-40 concentrations in patients with rheumatoid arthritis: Relation to disease activity
-
Johansen JS, Stoltenberg M, Hansen M et al.: Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity. Rheumatology 38, 618-626 (1999).
-
(1999)
Rheumatology
, vol.38
, pp. 618-626
-
-
Johansen, J.S.1
Stoltenberg, M.2
Hansen, M.3
-
148
-
-
0034775870
-
Serum YKL-40 concentrations in patients with early rheumatoid arthritis: Relation to joint destruction
-
Johansen JS, Kirwan JR, Price PA, Sharif M: Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction. Scand. J. Rheumatol. 30, 297-304 (2001).
-
(2001)
Scand. J. Rheumatol
, vol.30
, pp. 297-304
-
-
Johansen, J.S.1
Kirwan, J.R.2
Price, P.A.3
Sharif, M.4
-
149
-
-
0034538927
-
The relationship between serum levels of YKL-40 and disease progression in patients with early rheumatoid arthritis
-
Harvey S, Whaley J, Eberhardt K: The relationship between serum levels of YKL-40 and disease progression in patients with early rheumatoid arthritis. Scand. J. Rheumatol. 29, 391-393 (2000).
-
(2000)
Scand. J. Rheumatol
, vol.29
, pp. 391-393
-
-
Harvey, S.1
Whaley, J.2
Eberhardt, K.3
-
150
-
-
0033947786
-
Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions
-
Vos K, Steenbakkers P, Miltenburg AMM et al.: Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions. Ann. Rheum. Dis. 59, 544-548 (2000).
-
(2000)
Ann. Rheum. Dis
, vol.59
, pp. 544-548
-
-
Vos, K.1
Steenbakkers, P.2
Miltenburg, A.M.M.3
-
151
-
-
0034892658
-
Prognostic factors for radiographic damage in early rheumatoid arthritis: A multiparameter prospective study
-
Combe B, Dougados M, Goupille P et al.: Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis Rheum. 44, 1736-1743 (2001).
-
(2001)
Arthritis Rheum
, vol.44
, pp. 1736-1743
-
-
Combe, B.1
Dougados, M.2
Goupille, P.3
-
152
-
-
0034917476
-
Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: A new marker for disease activity
-
Peltomaa R, Paimela L, Harvey S, Helve T, Leirisalo-Repo M: Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity. Rheumatol. Int. 20, 192-196 (2001).
-
(2001)
Rheumatol. Int
, vol.20
, pp. 192-196
-
-
Peltomaa, R.1
Paimela, L.2
Harvey, S.3
Helve, T.4
Leirisalo-Repo, M.5
-
153
-
-
0035661247
-
Serum YKL-40 levels in rheumatoid arthritis: Correlations between clinical and laboratory parameters
-
Matsumoto T, Tsurumoto T: Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laboratory parameters. Clin. Exp. Rheumatol. 19, 655-660 (2001).
-
(2001)
Clin. Exp. Rheumatol
, vol.19
, pp. 655-660
-
-
Matsumoto, T.1
Tsurumoto, T.2
-
154
-
-
33947585113
-
Plasma IL-6, plasma VEGF and serum YKL-40: Relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate
-
Knudsen LS, Østergaard M, Baslund B et al.: Plasma IL-6, plasma VEGF and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate. Scand. J. Rheumatol. 35, 489-491 (2006).
-
(2006)
Scand. J. Rheumatol
, vol.35
, pp. 489-491
-
-
Knudsen, L.S.1
Østergaard, M.2
Baslund, B.3
-
155
-
-
47349091628
-
Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome
-
Knudsen LS, Klarlund M, Skjødt H et al.: Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome. J. Rheumatol. 35, 1277-1287 (2008).
-
(2008)
J. Rheumatol
, vol.35
, pp. 1277-1287
-
-
Knudsen, L.S.1
Klarlund, M.2
Skjødt, H.3
-
156
-
-
58149308830
-
YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages
-
Letuve S, Kozhich A, Arouche N et al.: YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J. Immunol. 181, 5167-5173 (2008).
-
(2008)
J. Immunol
, vol.181
, pp. 5167-5173
-
-
Letuve, S.1
Kozhich, A.2
Arouche, N.3
-
157
-
-
0141865738
-
Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of disease
-
Montagna GL, D'Angelo S, Valentini G: Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of disease. J. Rheumatol. 30, 2147-2151 (2003).
-
(2003)
J. Rheumatol
, vol.30
, pp. 2147-2151
-
-
Montagna, G.L.1
D'Angelo, S.2
Valentini, G.3
-
158
-
-
24044496956
-
High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement
-
Nordenbæk C, Johansen JS, Halberg P et al.: High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement. Scand. J. Rheumatol. 34, 293-297 (2005).
-
(2005)
Scand. J. Rheumatol
, vol.34
, pp. 293-297
-
-
Nordenbæk, C.1
Johansen, J.S.2
Halberg, P.3
-
159
-
-
33645815907
-
YKL-40, a biomarker of inflammation, is elevated in patients with Type 2 diabetes and is related to insulin resistance
-
Rathcke CN, Johansen JS, Vestergaard H: YKL-40, a biomarker of inflammation, is elevated in patients with Type 2 diabetes and is related to insulin resistance. Inflamm. Res. 55, 53-59 (2006).
-
(2006)
Inflamm. Res
, vol.55
, pp. 53-59
-
-
Rathcke, C.N.1
Johansen, J.S.2
Vestergaard, H.3
-
160
-
-
58149352840
-
Plasma YKL-40: A BMI-independent marker of Type 2 diabetes
-
Nielsen AR, Erikstrup C, Johansen JS et al.: Plasma YKL-40: a BMI-independent marker of Type 2 diabetes. Diabetes 57, 3078-3082 (2008).
-
(2008)
Diabetes
, vol.57
, pp. 3078-3082
-
-
Nielsen, A.R.1
Erikstrup, C.2
Johansen, J.S.3
-
161
-
-
61849086267
-
YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with Type 1 diabetes and increases with levels of albuminuria
-
Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H: YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with Type 1 diabetes and increases with levels of albuminuria. Diabetes Care 32, 323-328 (2009).
-
(2009)
Diabetes Care
, vol.32
, pp. 323-328
-
-
Rathcke, C.N.1
Persson, F.2
Tarnow, L.3
Rossing, P.4
Vestergaard, H.5
-
162
-
-
54749135440
-
Serum levels of YKL-40 increases in patients with acute myocardial infarction
-
Nøjgaard C, Høst NB, Christensen IJ et al.: Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coron. Artery Dis. 19, 257-263 (2008).
-
(2008)
Coron. Artery Dis
, vol.19
, pp. 257-263
-
-
Nøjgaard, C.1
Høst, N.B.2
Christensen, I.J.3
-
163
-
-
55449115890
-
YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease
-
Wang Y, Ripa RS, Johansen JS et al.: YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease. Scand. Card. J. 42, 295-302 (2008).
-
(2008)
Scand. Card. J
, vol.42
, pp. 295-302
-
-
Wang, Y.1
Ripa, R.S.2
Johansen, J.S.3
-
164
-
-
34547531506
-
Serum YKL-40 levels in patients with coronary artery disease
-
Kucur M, Isman FK, Karadag B, Vural VA, Tavsanoglu S: Serum YKL-40 levels in patients with coronary artery disease. Coron. Artery Dis. 18, 391-396 (2007).
-
(2007)
Coron. Artery Dis
, vol.18
, pp. 391-396
-
-
Kucur, M.1
Isman, F.K.2
Karadag, B.3
Vural, V.A.4
Tavsanoglu, S.5
-
165
-
-
65949119755
-
High serum concentration of YKL-40 in patients with stable coronary artery disease is associated with increased risk of myocardial infarction, cardiovascular death and all-cause mortality
-
Kastrup J, Johansen JS, Winkel P et al.: High serum concentration of YKL-40 in patients with stable coronary artery disease is associated with increased risk of myocardial infarction, cardiovascular death and all-cause mortality. Eur. Heart J. 30, 1066-1072 (2009).
-
(2009)
Eur. Heart J
, vol.30
, pp. 1066-1072
-
-
Kastrup, J.1
Johansen, J.S.2
Winkel, P.3
-
166
-
-
65549134577
-
Low grade inflammation as measured by levels of YKL-40: Association with an increased overall and cardiovascular mortality rate in an elderly population
-
Epub ahead of print
-
Rathcke CN, Raymond I, Kistorp C, Hildebrandt P, Faber J, Vestergaard H: Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population. Int. J. Card. (2009) (Epub ahead of print).
-
(2009)
Int. J. Card
-
-
Rathcke, C.N.1
Raymond, I.2
Kistorp, C.3
Hildebrandt, P.4
Faber, J.5
Vestergaard, H.6
-
167
-
-
0038141197
-
Increased serum levels of YKL-40 in patients with inflammatory bowel disease
-
Koutroubakis IE, Petinaki E, Dimoulios P et al.: Increased serum levels of YKL-40 in patients with inflammatory bowel disease. Int. J. Colorectal Dis. 18, 254-259 (2003).
-
(2003)
Int. J. Colorectal Dis
, vol.18
, pp. 254-259
-
-
Koutroubakis, I.E.1
Petinaki, E.2
Dimoulios, P.3
-
168
-
-
0345490894
-
Serum human cartilage glycoprotein 39 as a marker of arthritis associated with inflammatory bowel disease
-
Punzi L, Podswiadek M, D'Inca R et al.: Serum human cartilage glycoprotein 39 as a marker of arthritis associated with inflammatory bowel disease. Ann. Rheum. Dis. 62, 1224-1226 (2003).
-
(2003)
Ann. Rheum. Dis
, vol.62
, pp. 1224-1226
-
-
Punzi, L.1
Podswiadek, M.2
D'Inca, R.3
-
169
-
-
0037973676
-
Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease
-
Vind I, Johansen JS, Price PA, Munkholm P: Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 38, 599-605 (2003).
-
(2003)
Scand. J. Gastroenterol
, vol.38
, pp. 599-605
-
-
Vind, I.1
Johansen, J.S.2
Price, P.A.3
Munkholm, P.4
-
170
-
-
48549087887
-
Serum YKL-40 as a marker of disease activity and stricture formation in patiens with Crohn's disease
-
Erzin Y, Uzun H, Karatas A, Celik AF: Serum YKL-40 as a marker of disease activity and stricture formation in patiens with Crohn's disease. J. Gastroenterol. Hepatol. 23, E357-E362 (2008).
-
(2008)
J. Gastroenterol. Hepatol
, vol.23
-
-
Erzin, Y.1
Uzun, H.2
Karatas, A.3
Celik, A.F.4
-
171
-
-
0033831478
-
Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease
-
Tran A, Benzaken S, Saint-Paul MC et al.: Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease. Eur. J. Gastroenterol. Hepatol. 12, 989-993 (2000).
-
(2000)
Eur. J. Gastroenterol. Hepatol
, vol.12
, pp. 989-993
-
-
Tran, A.1
Benzaken, S.2
Saint-Paul, M.C.3
-
173
-
-
0037635401
-
Effect of antiviral therapy on markers of fibrogenesis in patients with chronic hepatitis C
-
Nøjgaard C, Johansen JS, Krarup HB et al.: Effect of antiviral therapy on markers of fibrogenesis in patients with chronic hepatitis C. Scand. J. Gastroenterol. 38, 659-665 (2003).
-
(2003)
Scand. J. Gastroenterol
, vol.38
, pp. 659-665
-
-
Nøjgaard, C.1
Johansen, J.S.2
Krarup, H.B.3
-
174
-
-
27944503359
-
HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease
-
Nunes D, Fleming C, Offner G et al.: HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J. Acquir. Immune Defic. Syndr. 40, 538-544 (2005).
-
(2005)
J. Acquir. Immune Defic. Syndr
, vol.40
, pp. 538-544
-
-
Nunes, D.1
Fleming, C.2
Offner, G.3
-
175
-
-
26844445531
-
Determination of serum levels of YKL-40 and hyaluronic acid in patients with hepatic fibrosis due to schistosomiasis japonica and appraisal of their clinical value
-
Zheng M, Cai WM, Zhao JK, Zhu SM, Liu RH: Determination of serum levels of YKL-40 and hyaluronic acid in patients with hepatic fibrosis due to schistosomiasis japonica and appraisal of their clinical value. Acta Trop. 96, 148-152 (2005).
-
(2005)
Acta Trop
, vol.96
, pp. 148-152
-
-
Zheng, M.1
Cai, W.M.2
Zhao, J.K.3
Zhu, S.M.4
Liu, R.H.5
-
176
-
-
33645986652
-
Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis
-
Kamal SM, Turner B, He Q et al.: Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology 43, 771-779 (2006).
-
(2006)
Hepatology
, vol.43
, pp. 771-779
-
-
Kamal, S.M.1
Turner, B.2
He, Q.3
-
177
-
-
34247638591
-
Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: Results of a pilot study
-
Alexander J, Tung BY, Croghan A, Kowdley KV: Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study. Liver Int. 27, 268-273 (2007).
-
(2007)
Liver Int
, vol.27
, pp. 268-273
-
-
Alexander, J.1
Tung, B.Y.2
Croghan, A.3
Kowdley, K.V.4
-
178
-
-
33947145201
-
Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C
-
Esmat G, Metwally M, Zalata KR et al: Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C. J. Hepatol. 46, 620-627 (2007).
-
(2007)
J. Hepatol
, vol.46
, pp. 620-627
-
-
Esmat, G.1
Metwally, M.2
Zalata, K.R.3
-
179
-
-
40949145677
-
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C
-
Fontana RJ, Goodman ZD, Dienstag JL et al.: Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology 47, 789-798 (2008).
-
(2008)
Hepatology
, vol.47
, pp. 789-798
-
-
Fontana, R.J.1
Goodman, Z.D.2
Dienstag, J.L.3
-
180
-
-
58849097713
-
Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis
-
Fontana RJ, Bonkovsky HL, Naishadham D et al.: Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis. Clin. Gastroenterol. Hepatol. 7, 219-226 (2009).
-
(2009)
Clin. Gastroenterol. Hepatol
, vol.7
, pp. 219-226
-
-
Fontana, R.J.1
Bonkovsky, H.L.2
Naishadham, D.3
-
181
-
-
39749178476
-
Serum level of YKL-40 does not predict advanced liver fibrosis in children with chronic hepatitis B
-
Lebensztejn DM, Skiba E, Werpachowska I, Sobaniec-Lotowska ME, Kaczmarksi M: Serum level of YKL-40 does not predict advanced liver fibrosis in children with chronic hepatitis B. Adv. Med. Sci. 52, 120-124 (2007).
-
(2007)
Adv. Med. Sci
, vol.52
, pp. 120-124
-
-
Lebensztejn, D.M.1
Skiba, E.2
Werpachowska, I.3
Sobaniec-Lotowska, M.E.4
Kaczmarksi, M.5
-
182
-
-
51349083802
-
Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C
-
Pungpapong S, Nunes DP, Krishna M et al.: Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C. Liver Transpl. 14, 1294-1302 (2008).
-
(2008)
Liver Transpl
, vol.14
, pp. 1294-1302
-
-
Pungpapong, S.1
Nunes, D.P.2
Krishna, M.3
-
183
-
-
41849135398
-
Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C
-
Mehta P, Ploutz-Snyder R, Nandi J, Rawlins SR, Sanderson SO, Levine RA: Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C. Am. J. Gastroenterol. 103, 928-936 (2008).
-
(2008)
Am. J. Gastroenterol
, vol.103
, pp. 928-936
-
-
Mehta, P.1
Ploutz-Snyder, R.2
Nandi, J.3
Rawlins, S.R.4
Sanderson, S.O.5
Levine, R.A.6
-
184
-
-
49649094025
-
Serum levels of YKL-40 and hyaluronic acid as non-invasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection
-
Schiavon LL, Narciso-Schiavon JL, Carvalho Filho RJ et al.: Serum levels of YKL-40 and hyaluronic acid as non-invasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection. J. Viral Hepat. 15, 666-674 (2008).
-
(2008)
J. Viral Hepat
, vol.15
, pp. 666-674
-
-
Schiavon, L.L.1
Narciso-Schiavon, J.L.2
Carvalho Filho, R.J.3
-
185
-
-
55249105922
-
Elevated C-reactive protein in atherosclerosis - chicken or egg?
-
Schunkert H, Samani NJ: Elevated C-reactive protein in atherosclerosis - chicken or egg? N. Engl. J. Med. 359, 1953-1955 (2008).
-
(2008)
N. Engl. J. Med
, vol.359
, pp. 1953-1955
-
-
Schunkert, H.1
Samani, N.J.2
-
186
-
-
38549119828
-
Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): A novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection
-
Nielsen HJ, Brünner, Frederiksen C et al.: Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection. Scand. J. Gastroenterol. 43, 242-248 (2008).
-
(2008)
Scand. J. Gastroenterol
, vol.43
, pp. 242-248
-
-
Nielsen, H.J.1
Brünner, F.C.2
-
187
-
-
75249086147
-
Nielsen HJ; the Danish Colorectal Cancer Study Group: Serum YKL-40 in risk assessment for colorectal cancer. A population based, prospective study of 4987 subjects at risk of colorectal cancer
-
Abstract 4136
-
Johansen JS, Christensen IJ, Price PA, Nielsen HJ; the Danish Colorectal Cancer Study Group: Serum YKL-40 in risk assessment for colorectal cancer. A population based, prospective study of 4987 subjects at risk of colorectal cancer. ASCO Ann. Meet. Proc. 26, 212 (2008) (Abstract 4136).
-
(2008)
ASCO Ann. Meet. Proc
, vol.26
, pp. 212
-
-
Johansen, J.S.1
Christensen, I.J.2
Price, P.A.3
-
188
-
-
0029094048
-
Serum YKL-40: A new potential marker of prognosis and location of metastases of patients with recurrent breast cancer
-
Johansen JS, Cintin C, Jørgensen M, Kamby C, Price PA: Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur. J. Cancer 31A, 1437-1442 (1995).
-
(1995)
Eur. J. Cancer
, vol.31 A
, pp. 1437-1442
-
-
Johansen, J.S.1
Cintin, C.2
Jørgensen, M.3
Kamby, C.4
Price, P.A.5
-
189
-
-
0141960434
-
High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer
-
Jensen BV, Johansen JS, Price PA: High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. Clin. Cancer Res. 9, 501-512 (2003).
-
(2003)
Clin. Cancer Res
, vol.9
, pp. 501-512
-
-
Jensen, B.V.1
Johansen, J.S.2
Price, P.A.3
-
190
-
-
0037485763
-
High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival
-
Johansen JS, Christensen IJ, Riisbro R et al.: High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res. Treat. 80, 15-21 (2003).
-
(2003)
Breast Cancer Res. Treat
, vol.80
, pp. 15-21
-
-
Johansen, J.S.1
Christensen, I.J.2
Riisbro, R.3
-
191
-
-
35448956544
-
Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: Are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?
-
Coskun U, Yamac D, Gulbahar O, Sancak B, Karaman N, Ozkan S: Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response? Neoplasma 54, 348-352 (2007).
-
(2007)
Neoplasma
, vol.54
, pp. 348-352
-
-
Coskun, U.1
Yamac, D.2
Gulbahar, O.3
Sancak, B.4
Karaman, N.5
Ozkan, S.6
-
192
-
-
58749083936
-
Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer
-
Yamac D, Ozturk B, Coskun U et al.: Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer. Adv. Ther. 25, 801-809 (2008).
-
(2008)
Adv. Ther
, vol.25
, pp. 801-809
-
-
Yamac, D.1
Ozturk, B.2
Coskun, U.3
-
193
-
-
0032974075
-
Serum YKL-40 and colorectal cancer
-
Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ: Serum YKL-40 and colorectal cancer. Br. J. Cancer 79, 1494-1499 (1999).
-
(1999)
Br. J. Cancer
, vol.79
, pp. 1494-1499
-
-
Cintin, C.1
Johansen, J.S.2
Christensen, I.J.3
Price, P.A.4
Sørensen, S.5
Nielsen, H.J.6
-
194
-
-
0037099560
-
High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival
-
Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ: High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer 95, 267-274 (2002).
-
(2002)
Cancer
, vol.95
, pp. 267-274
-
-
Cintin, C.1
Johansen, J.S.2
Christensen, I.J.3
Price, P.A.4
Sørensen, S.5
Nielsen, H.J.6
-
195
-
-
75249105388
-
Association of biomarkers of inflammation and YKL-40 with survival of patients with metastatic colorectal cancer
-
Orlando, FL, USA , Abstract 323
-
Jensen BV, Qvortrup C, Christensen IJ et al.: Association of biomarkers of inflammation and YKL-40 with survival of patients with metastatic colorectal cancer. Proceedings of 2008 Gastrointestinal Cancer Symposium. Orlando, FL, USA (2008) (Abstract 323).
-
(2008)
Proceedings of 2008 Gastrointestinal Cancer Symposium
-
-
Jensen, B.V.1
Qvortrup, C.2
Christensen, I.J.3
-
196
-
-
1242312462
-
High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival
-
Høgdall EVS, Johansen JS, Kjaer SK et al.: High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. Oncol. Rep. 10, 1535-1538 (2003).
-
(2003)
Oncol. Rep
, vol.10
, pp. 1535-1538
-
-
Høgdall, E.V.S.1
Johansen, J.S.2
Kjaer, S.K.3
-
197
-
-
0037361965
-
Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer
-
Dehn H, Høgdall EVS, Johansen JS et al.: Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer. Acta Obstet. Gynecol. Scand. 82, 287-293 (2003).
-
(2003)
Acta Obstet. Gynecol. Scand
, vol.82
, pp. 287-293
-
-
Dehn, H.1
Høgdall, E.V.S.2
Johansen, J.S.3
-
198
-
-
4344704083
-
Early detection and prognosis of ovarian cancer using serum YKL-40
-
Addresses YKL-40 and early detection of ovarian cancer, •
-
Dupont J, Tanwar MK, Thaler HT et al.: Early detection and prognosis of ovarian cancer using serum YKL-40. J. Clin. Oncol. 22, 3330-3339 (2004). • Addresses YKL-40 and early detection of ovarian cancer.
-
(2004)
J. Clin. Oncol
, vol.22
, pp. 3330-3339
-
-
Dupont, J.1
Tanwar, M.K.2
Thaler, H.T.3
-
199
-
-
33750505450
-
Pre-treatment prediction of chemoresistance in second-line chemotherapy of ovarian carcinoma: Value of serological tumor marker determination (tetranectin, YKL-40, CASA, CA125)
-
Grønlund B, Høgdall EVS, Christensen IJ et al.: Pre-treatment prediction of chemoresistance in second-line chemotherapy of ovarian carcinoma: value of serological tumor marker determination (tetranectin, YKL-40, CASA, CA125). Int. J. Biol. Markers 21, 141-148 (2006).
-
(2006)
Int. J. Biol. Markers
, vol.21
, pp. 141-148
-
-
Grønlund, B.1
Høgdall, E.V.S.2
Christensen, I.J.3
-
200
-
-
61849164601
-
YKL-40 tissue expression and plasma levels in patients with ovarian cancer
-
Høgdall EVS, Ringsholt M, Høgdall CK et al.: YKL-40 tissue expression and plasma levels in patients with ovarian cancer. BMC Cancer 9, 8 (2009).
-
(2009)
BMC Cancer
, vol.9
, pp. 8
-
-
Høgdall, E.V.S.1
Ringsholt, M.2
Høgdall, C.K.3
-
201
-
-
40449135660
-
Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer
-
Fredriksson S, Horecka J, Brustugun OT et al.: Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer. Clin. Chem. 54, 582-589 (2008).
-
(2008)
Clin. Chem
, vol.54
, pp. 582-589
-
-
Fredriksson, S.1
Horecka, J.2
Brustugun, O.T.3
-
202
-
-
8444236654
-
High serum YKL-40 level in patients with small cell lung cancer is related to early death
-
Johansen JS, Drivsholm L, Price PA, Christensen IJ: High serum YKL-40 level in patients with small cell lung cancer is related to early death. Lung Cancer 46, 333-340 (2004).
-
(2004)
Lung Cancer
, vol.46
, pp. 333-340
-
-
Johansen, J.S.1
Drivsholm, L.2
Price, P.A.3
Christensen, I.J.4
-
203
-
-
75249097523
-
Elevated pretreatment serum concentration of YKL-40 - an independent prognostic biomarker for poor survival in patients with metastatic non-small cell lung cancer
-
Abstract 313P
-
Thöm I, Adritzky B, Schuch G et al.: Elevated pretreatment serum concentration of YKL-40 - an independent prognostic biomarker for poor survival in patients with metastatic non-small cell lung cancer. Ann. Oncol. 19(Suppl. 8) (2008) (Abstract 313P).
-
(2008)
Ann. Oncol
, Issue.SUPPL. 8
, pp. 19
-
-
Thöm, I.1
Adritzky, B.2
Schuch, G.3
-
204
-
-
33645351695
-
Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma
-
Brasso K, Christensen IJ, Johansen JS et al.: Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma. Prostate 66, 503-513 (2006).
-
(2006)
Prostate
, vol.66
, pp. 503-513
-
-
Brasso, K.1
Christensen, I.J.2
Johansen, J.S.3
-
205
-
-
34250648459
-
Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival
-
Johansen JS, Brasso K, Iversen P et al.: Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival. Clin. Cancer Res. 13, 3244-3249 (2007).
-
(2007)
Clin. Cancer Res
, vol.13
, pp. 3244-3249
-
-
Johansen, J.S.1
Brasso, K.2
Iversen, P.3
-
206
-
-
37649015894
-
Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia
-
Kucur M, Isman FK, Balci C, Onal B, Hacibekiroglu M, Ozkan F: Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urol. Oncol. 26, 47-52 (2008).
-
(2008)
Urol. Oncol
, vol.26
, pp. 47-52
-
-
Kucur, M.1
Isman, F.K.2
Balci, C.3
Onal, B.4
Hacibekiroglu, M.5
Ozkan, F.6
-
207
-
-
33644512815
-
High pretreatment serum level of YKL-40 is related to short survival in patients with advanced renal cell carcinoma treated with high-dose continuous intravenous infusion of interleukin-2
-
Abstract 1603
-
Geertsen PF, Johansen JS, von der Maase H, Jensen BV, Price PA: High pretreatment serum level of YKL-40 is related to short survival in patients with advanced renal cell carcinoma treated with high-dose continuous intravenous infusion of interleukin-2. Ann. Meet. Proc. 22, 399 (2003) (Abstract 1603).
-
(2003)
Ann. Meet. Proc
, vol.22
, pp. 399
-
-
Geertsen, P.F.1
Johansen, J.S.2
von der Maase, H.3
Jensen, B.V.4
Price, P.A.5
-
208
-
-
75249100497
-
Plasma YKL-40, a potential new biomarker for advanced upper gastrointestinal adenocarcinomas
-
Presented at:, CA, USA, 15-17 January, Abstract 176
-
Schultz NA, Berglund Å, Johansen et al.: Plasma YKL-40, a potential new biomarker for advanced upper gastrointestinal adenocarcinomas. Presented at: 2009 Gastrointestinal Cancer Symposium. CA, USA, 15-17 January 2009 (Abstract 176).
-
(2009)
2009 Gastrointestinal Cancer Symposium
-
-
Schultz, N.A.1
Berglund, A.2
Johansen3
-
209
-
-
33846525654
-
Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer
-
Diefenbach CS, Shah Z, Iasonos A et al.: Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer. Gynecol. Oncol. 104, 435-442 (2007).
-
(2007)
Gynecol. Oncol
, vol.104
, pp. 435-442
-
-
Diefenbach, C.S.1
Shah, Z.2
Iasonos, A.3
-
210
-
-
33846675418
-
Serum YKL-40 levels in patients with cervical cancer are elevated compared with patients with cervical intraepithelial neoplasia and healthy controls
-
Abstract 5047
-
Johansen JS, Roslind A, Palle C et al.: Serum YKL-40 levels in patients with cervical cancer are elevated compared with patients with cervical intraepithelial neoplasia and healthy controls. ASCO Ann. Meet. Proc. 24, 267 (2006) (Abstract 5047).
-
(2006)
ASCO Ann. Meet. Proc
, vol.24
, pp. 267
-
-
Johansen, J.S.1
Roslind, A.2
Palle, C.3
-
211
-
-
58949083842
-
Serum YKL-40 as a marker for cervical adenocarcinoma
-
Mitsuhashi A, Matsui H, Usui H et al.: Serum YKL-40 as a marker for cervical adenocarcinoma. Ann. Oncol. 20, 71-77 (2009).
-
(2009)
Ann. Oncol
, vol.20
, pp. 71-77
-
-
Mitsuhashi, A.1
Matsui, H.2
Usui, H.3
-
212
-
-
38349076275
-
High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival
-
Roslind A, Johansen JS, Christensen IJ et al.: High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival. Int. J. Cancer 122, 857-863 (2008).
-
(2008)
Int. J. Cancer
, vol.122
, pp. 857-863
-
-
Roslind, A.1
Johansen, J.S.2
Christensen, I.J.3
-
213
-
-
33750316189
-
YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas
-
Hormigo A, Gu B, Karimi S et al.: YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas. Clin. Cancer Res. 12, 5698-5704 (2006).
-
(2006)
Clin. Cancer Res
, vol.12
, pp. 5698-5704
-
-
Hormigo, A.1
Gu, B.2
Karimi, S.3
-
214
-
-
33644534470
-
Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma
-
Schmidt H, Johansen JS, Gehl J, Geertsen PF, Fode K, von der Maase H: Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma. Cancer 106, 1130-1139 (2006).
-
(2006)
Cancer
, vol.106
, pp. 1130-1139
-
-
Schmidt, H.1
Johansen, J.S.2
Gehl, J.3
Geertsen, P.F.4
Fode, K.5
von der Maase, H.6
-
215
-
-
33644850748
-
Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma
-
Discusses YKL-40 as a prognostic marker and a marker to monitor after operation, •
-
Schmidt H, Johansen JS, Sjoegren P et al.: Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma. J. Clin. Oncol. 24, 798-804 (2006). • Discusses YKL-40 as a prognostic marker and a marker to monitor after operation.
-
(2006)
J. Clin. Oncol
, vol.24
, pp. 798-804
-
-
Schmidt, H.1
Johansen, J.S.2
Sjoegren, P.3
-
216
-
-
75249088976
-
Predictive and prognostic value of serum YKL-40 post surgery in patients with stage IIB-III melanoma receiving adjvant interferon therapy
-
Presented at:, The Hague, The Netherlands, 2-4 October
-
Krogh M, Bastholt L, Johansen JS et al.: Predictive and prognostic value of serum YKL-40 post surgery in patients with stage IIB-III melanoma receiving adjvant interferon therapy. Presented at: Perspectives in Melanoma XII. The Hague, The Netherlands, 2-4 October 2008.
-
(2008)
Perspectives in Melanoma XII
-
-
Krogh, M.1
Bastholt, L.2
Johansen, J.S.3
-
217
-
-
29344449079
-
High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia
-
Bergmann OJ, Johansen JS, Klausen TW et al.: High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia. Clin. Cancer Res. 11, 8644-8652 (2005).
-
(2005)
Clin. Cancer Res
, vol.11
, pp. 8644-8652
-
-
Bergmann, O.J.1
Johansen, J.S.2
Klausen, T.W.3
-
218
-
-
40449134510
-
High serum YKL-40 concentration is associated with severe bone disease in newly diagnosed multiple myeloma patients
-
Mylin AK, Abildgaard N, Johansen JS et al.: High serum YKL-40 concentration is associated with severe bone disease in newly diagnosed multiple myeloma patients. Eur. J. Haematol. 80, 310-317 (2008).
-
(2008)
Eur. J. Haematol
, vol.80
, pp. 310-317
-
-
Mylin, A.K.1
Abildgaard, N.2
Johansen, J.S.3
-
219
-
-
60549092917
-
Serum YKL-40 and bone marrow angiogenesis in multiple myeloma
-
Mylin AK, Andersen NF, Johansen JS et al.: Serum YKL-40 and bone marrow angiogenesis in multiple myeloma. Int. J. Cancer 124, 1492-1494 (2009).
-
(2009)
Int. J. Cancer
, vol.124
, pp. 1492-1494
-
-
Mylin, A.K.1
Andersen, N.F.2
Johansen, J.S.3
-
220
-
-
58149241012
-
Serum YKL-40 and IL-6 levels in Hodgkin lymphoma
-
Biggar RJ, Johansen JS, Smedby KE et al.: Serum YKL-40 and IL-6 levels in Hodgkin lymphoma. Clin. Cancer Res. 14, 6974-6979 (2008).
-
(2008)
Clin. Cancer Res
, vol.14
, pp. 6974-6979
-
-
Biggar, R.J.1
Johansen, J.S.2
Smedby, K.E.3
-
221
-
-
0035868668
-
update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology
-
Discusses biomarkers in breast cancer and colorectal cancer, ••
-
Bast RC Jr, Ravdin P, Hayes DF et al.: 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 19, 1865-1878 (2001). •• Discusses biomarkers in breast cancer and colorectal cancer.
-
(2000)
J. Clin. Oncol
, vol.19
, pp. 1865-1878
-
-
Bast Jr, R.C.1
Ravdin, P.2
Hayes, D.F.3
-
222
-
-
10244261646
-
Tumor Marker Utility Grading System: A framework to evaluate clinical utility of tumor markers
-
General description of tumor biomarkers, ••
-
Hayes DF, Bast RC, Desch CE et al.: Tumor Marker Utility Grading System: a framework to evaluate clinical utility of tumor markers. J. Natl. Cancer Inst. 88, 1456-1466 (1996). •• General description of tumor biomarkers.
-
(1996)
J. Natl. Cancer Inst
, vol.88
, pp. 1456-1466
-
-
Hayes, D.F.1
Bast, R.C.2
Desch, C.E.3
-
223
-
-
0032241729
-
Determination of clinical utility of tumor markers: A tumor marker utility grading system
-
General description of tumor biomarkers, ••
-
Hayes DF: Determination of clinical utility of tumor markers: a tumor marker utility grading system. Recent Results Cancer Res. 152, 71-85 (1998). •• General description of tumor biomarkers.
-
(1998)
Recent Results Cancer Res
, vol.152
, pp. 71-85
-
-
Hayes, D.F.1
-
224
-
-
0027360384
-
Clinical utility and validation of emerging biochemical markers for mammary adenocarcinoma
-
Werner M, Fraser C, Silverberg M: Clinical utility and validation of emerging biochemical markers for mammary adenocarcinoma. Clin. Chem. 39, 2386-2396 (1993).
-
(1993)
Clin. Chem
, vol.39
, pp. 2386-2396
-
-
Werner, M.1
Fraser, C.2
Silverberg, M.3
-
225
-
-
84874353910
-
-
National Cancer for Biotechnology Information
-
National Cancer for Biotechnology Information. Expressed Sequence Tags database www.ncbi.nlm.nih.gov/dbEST
-
Expressed Sequence Tags database
-
-
|